TACR1 and migraine disorder: The explanation for the failure of NK-1 receptor antagonists as analgesics and anti-migraine drugs remains unclear, but it might be due to differences of the human NK-1 receptor structure and function as compared to the rodent receptor, or the ineffectiveness of competitively blocking the SP binding site [28,29].